RARE News

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Ultragenyx Pharmaceutical Inc. – RARE

RARE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Ultragenyx Pharmaceutical Inc. – RARE

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Pomerantz LLP Advises Shareholders of Class Action Filing Against Ultragenyx Pharmaceutical Inc. – RARE

RARE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Alerts Shareholders to Investor Suit Against Ultragenyx Pharmaceutical Inc. – RARE

Pomerantz LLP Advises Shareholders of Class Action Against Ultragenyx Pharmaceutical Inc. – RARE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RARE